This tutorial presents a systematic approach to the management of diarrhea in the critical care setting. Diarrhea is a common and prevalent problem in critically ill patients. Despite the high prevalence, its management is far from simple. Professionals are confronted with a myriad of definitions based on frequency, consistency, and volume. The causes are complex and multifactorial, yet enteral tube feeding formula is believed to be the perpetrator. Potential causes for diarrhea are discussed, and 3 case reports provide context to examine the treatment from a nutrition perspective. Each scenario is comprehensively addressed discussing potential causes and providing specific clinical strategies contributing to improved bowel function in this patient group. The approach used for diarrhea management is based on a complete understanding of enteral tube formula, their composition, and their impact in the presence of gut dysfunction. Choosing the right feeding formula may positively influence bowel function and contribute to improved nutrition.
LeeJSAuyeungTW. A comparison of two feeding methods in the alleviation of diarrhoea in older tube-fed patients: a randomised controlled trial. Age Ageing. 2003;32(4):388-393.
2.
WiesenPVan GossumAPreiserJC. Diarrhoea in the critically ill. Curr Opin Crit Care. 2006;12(2):149-154.
3.
McNaughtCEWoodcockNPAndersonADMacFieJ. A prospective randomised trial of probiotics in critically ill patients. Clin Nutr. 2005;24(2):211-219.
4.
DeMeoMKolliSKeshavarzianA. Beneficial effect of a bile acid resin binder on enteral feeding induced diarrhea. Am J Gastroenterol. 1998;93(6):967-971.
5.
WhelanKJuddPATaylorMA. Defining and reporting diarrhoea during enteral tube feeding: do health professionals agree?J Hum Nutr Diet. 2003;16(1):21-26.
6.
BlissDZGuenterPASettleRG. Defining and reporting diarrhea in tube-fed patients—what a mess!Am J Clin Nutr. 1992;55(3):753-759.
7.
LordaniCRFEckertRGTozettoAGLordaniTVADuartePAD. The knowledge of intensive care professionals about diarrhea. Rev Bras Ter Intensiva. 2014;26(3):299-304.
8.
LebakKJBlissDZSavikKPatten-MarshKM. What’s new on defining diarrhea in tube-feeding studies?Clin Nurs Res. 2003;12(2):174-204.
9.
Zimmaro BlissDLarsonSJBurrJKSavikK. Reliability of a stool consistency classification system. J Wound Ostomy Continence Nurs. 2001;28(6):305-313.
10.
LewisSJHeatonKW. Stool form scale as a useful guide to intestinal transit time. Scand J Gastroenterol. 1997;32(9):920-924.
11.
WhelanKJuddPAPreedyVRTaylorMA. Enteral feeding: the effect on faecal output, the faecal microflora and SCFA concentrations. Proc Nutr Soc. 2004;63(1):105-113.
12.
WhelanKJuddPATaylorMA. Assessment of fecal output in patients receiving enteral tube feeding: validation of a novel chart. Eur J Clin Nutr. 2004;58(7):1030-1037.
13.
FerrieSEastV. Managing diarrhoea in intensive care. Aust Crit Care. 2007;20(1):7-13.
14.
WierdsmaNJPetersJHWeijsPJ. Malabsorption and nutritional balance in the ICU: fecal weight as a biomarker: a prospective observational pilot study. Crit Care. 2011;15(6):R264.
15.
WashingtonCCarmichaelJC. Management of ischemic colitis. Clin Colon Rectal Surg. 2012;25(4):228-235.
16.
LawrenceSJPuzniakLAShadelBNGillespieKNKollefMHMundyLM. Clostridium difficile in the intensive care unit: epidemiology, costs, and colonization pressure. Infect Control Hosp Epidemiol. 2007;28(2):123-130.
17.
ZilberbergMDShorrAF. Preventing Clostridium difficile infection in the intensive care unit. Crit Care Clin. 2013;29(1):11-18.
18.
Diaz NietoRVarcadaMOgunbiyiOAWinsletMC. Systematic review on the treatment of ischaemic colitis. Colorectal Dis. 2011;13(7):744-747.
19.
BrandtLJBoleySJ. Colonic ischemia. Surg Clin North Am. 1992;72(1):203-229.
20.
LioliosAOropelloJMBenjaminE. Gastrointestinal complications in the intensive care unit. Clin Chest Med. 1999;20(2):329-345, viii.
21.
Grundfest-BroniatowskiSQuaderMAlexanderFWalshRMLaveryIMilsomJ. Clostridium difficile colitis in the critically ill. Dis Colon Rectum. 1996;39(6):619-623.
22.
RiddleDJDubberkeER. Clostridium difficile infection in the intensive care unit. Infect Dis Clin North Am. 2009;23(3):727-743.
23.
BoboLDDubberkeERKollefM. Clostridium difficile in the ICU: the struggle continues. Chest. 2011;140(6):1643-1653.
24.
MarraAREdmondMBWenzelRPBearmanGM. Hospital-acquired Clostridium difficile–associated disease in the intensive care unit setting: epidemiology, clinical course and outcome. BMC Infect Dis. 2007;7:42.
25.
JumpRLPultzMJDonskeyCJ. Vegetative Clostridium difficile survives in room air on moist surfaces and in gastric contents with reduced acidity: a potential mechanism to explain the association between proton pump inhibitors and C. difficile–associated diarrhea?Antimicrob Agents Chemother. 2007;51(8):2883-2887.
BlissDZJohnsonSSavikKClabotsCRWillardKGerdingDN. Acquisition of Clostridium difficile and Clostridium difficile–associated diarrhea in hospitalized patients receiving tube feeding. Ann Intern Med. 1998;129(12):1012-1019.
28.
KozenieckiMFritzshallR. Enteral nutrition for adults in the hospital setting. Nutr Clin Pract. 2015;30(5):634-651.
29.
JuckettGTrivediR. Evaluation of chronic diarrhea. Am Fam Physician. 2011;84(10):1119-1126.
EisenbergPG. Causes of diarrhea in tube-fed patients: a comprehensive approach to diagnosis and management. Nutr Clin Pract. 1993;8(3):119-123.
32.
den BestenGvan EunenKGroenAKVenemaKReijngoudDJBakkerBM. The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism. J Lipid Res. 2013;54(9):2325-2340.
33.
ClausenMRMortensenPB. Kinetic studies on colonocyte metabolism of short chain fatty acids and glucose in ulcerative colitis. Gut. 1995;37(5):684-689.
34.
WhelanKJuddPATuohyKMGibsonGRPreedyVRTaylorMA. Fecal microbiota in patients receiving enteral feeding are highly variable and may be altered in those who develop diarrhea. Am J Clin Nutr. 2009;89(1):240-247.
35.
ChassanyOMichauxABergmannJF. Drug-induced diarrhoea. Drug Saf. 2000;22(1):53-72.
36.
JainNKPatelVPPitchumoniCS. Sorbitol intolerance in adults: prevalence and pathogenesis on two continents. J Clin Gastroenterol. 1987;9(3):317-319.
37.
ChangSJHuangHH. Diarrhea in enterally fed patients: blame the diet?Curr Opin Clin Nutr Metab Care. 2013;16(5):588-594.
38.
NguyenNQChingKFraserRJChapmanMJHollowayRH. Risk of Clostridium difficile diarrhoea in critically ill patients treated with erythromycin-based prokinetic therapy for feed intolerance. Intensive Care Med. 2008;34(1):169-173.
39.
KoecherKJThomasWSlavinJL. Healthy subjects experience bowel changes on enteral diets: addition of a fiber blend attenuates stool weight and gut bacteria decreases without changes in gas. JPEN J Parenter Enteral Nutr. 2015;39(3):337-343.
40.
ShankardassKChuchmachSChelswickK. Bowel function of long-term tube-fed patients consuming formulae with and without dietary fiber. JPEN J Parenter Enteral Nutr. 1990;14(5):508-512.
41.
McClaveSAMartindaleRGVanekVW. Guidelines for the provision and assessment of nutrition support therapy in the adult critically ill patient: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.). JPEN J Parenter Enteral Nutr. 2009;33(3):277-316.
42.
WhelanKSchneiderSM. Mechanisms, prevention, and management of diarrhea in enteral nutrition. Curr Opin Gastroenterol. 2011;27(2):152-159.
43.
SchneiderSMLe GallPGirard-PipauF. Total artificial nutrition is associated with major changes in the fecal flora. Eur J Nutr. 2000;39(6):248-255.
44.
BenusRFvan der WerfTSWellingGW. Association between Faecalibacterium prausnitzii and dietary fibre in colonic fermentation in healthy human subjects. Br J Nutr. 2010;104(5):693-700.
45.
SlavinJ. Fiber and prebiotics: mechanisms and health benefits. Nutrients. 2013;5(4):1417-1435.
46.
SchneiderSMGirard-PipauFAntyR. Effects of total enteral nutrition supplemented with a multi-fibre mix on faecal short-chain fatty acids and microbiota. Clin Nutr. Feb2006;25(1):82-90.
47.
GibsonGRRoberfroidMB. Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J Nutr. 1995;125(6):1401-1412.
48.
VandewoudeMFParidaensKMSuyRABooneMAStrobbeH. Fibre-supplemented tube feeding in the hospitalised elderly. Age Ageing. 2005;34(2):120-124.
49.
TrabalJLeyesPHervasSHerreraMde Tallo ForgaM. Factors associated with nosocomial diarrhea in patients with enteral tube feeding. Nutr Hosp. 2008;23(5):500-504.
50.
ThorsonMABlissDZSavikK. Re-examination of risk factors for non–Clostridium difficile-associated diarrhoea in hospitalized patients. J Adv Nurs. 2008;62(3):354-364.
HeylandDKMurchLCahillN. Enhanced protein-energy provision via the enteral route feeding protocol in critically ill patients: results of a cluster randomized trial. Crit Care Med. 2013;41(12):2743-2753.
53.
MacLeodJBLeftonJHoughtonD. Prospective randomized control trial of intermittent versus continuous gastric feeds for critically ill trauma patients. J Trauma. 2007;63(1):57-61.
54.
StroudMDuncanHNightingaleJ. Guidelines for enteral feeding in adult hospital patients. Gut. 2003;52(suppl 7):vii1-vii12.
55.
BussyVMarechalFNascaS. Microbial contamination of enteral feeding tubes occurring during nutritional treatment. JPEN J Parenter Enteral Nutr. 1992;16(6):552-557.
56.
WagnerDRElmoreMFKnollDM. Evaluation of “closed” vs “open” systems for the delivery of peptide-based enteral diets. JPEN J Parenter Enteral Nutr. 1994;18(5):453-457.
57.
ShahBSucherKHollenbeckCB. Comparison of ideal body weight equations and published height-weight tables with body mass index tables for healthy adults in the United States. Nutr Clin Pract. 2006;21(3):312-319.
58.
SlavinJL. Position of the American Dietetic Association: health implications of dietary fiber. J Am Diet Assoc. 2008;108(10):1716-1731.
59.
KlosterbuerARougheadZFSlavinJ. Benefits of dietary fiber in clinical nutrition. Nutr Clin Pract. 2011;26(5):625-635.
60.
EliaMEngferMBGreenCJSilkDB. Systematic review and meta-analysis: the clinical and physiological effects of fibre-containing enteral formulae. Aliment Pharmacol Ther. 2008;27(2):120-145.
61.
RushdiTAPichardCKhaterYH. Control of diarrhea by fiber-enriched diet in ICU patients on enteral nutrition: a prospective randomized controlled trial. Clin Nutr. 2004;23(6):1344-1352.
62.
del OlmoDLopez del ValTMartinez de IcayaP. Fiber in enteral nutrition: systematic review of the literature [in Spanish]. Nutr Hosp. 2004;19(3):167-174.
63.
YangGWuXTZhouYWangYL. Application of dietary fiber in clinical enteral nutrition: a meta-analysis of randomized controlled trials. World J Gastroenterol. 2005;11(25):3935-3938.
64.
TurzaKCKrenitskyJSawyerRG. Enteral feeding and vasoactive agents: suggested guidelines for clinicians. Nutr Issues Gastroenterol. 2009;78:11-22.
65.
MarvinRGMcKinleyBAMcQuigganMCocanourCSMooreFA. Nonocclusive bowel necrosis occurring in critically ill trauma patients receiving enteral nutrition manifests no reliable clinical signs for early detection. Am J Surg. 2000;179(1):7-12.
66.
DuzgunAPGulgezBOzmutluA. The relationship between intestinal hypoperfusion and serum d-lactate levels during experimental intra-abdominal hypertension. Dig Dis Sci. 2006;51(12):2400-2403.
67.
CresciGCueJ. The patient with circulatory shock: to feed or not to feed?Nutr Clin Pract. 2008;23(5):501-509.
68.
CustAESkiltonMRvan BakelMM. Total dietary carbohydrate, sugar, starch and fibre intakes in the European Prospective Investigation into Cancer and Nutrition. Eur J Clin Nutr. 2009;63(suppl 4):S37-S60.
69.
McClaveSATaylorBEMartindaleRG. Guidelines for the provision and assessment of nutrition support therapy in the adult critically ill patient: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.). JPEN J Parenter Enteral Nutr. 2016;40(2):159-211.
70.
de Aguilar-NascimentoJEPrado SilveiraBRDock-NascimentoDB. Early enteral nutrition with whey protein or casein in elderly patients with acute ischemic stroke: a double-blind randomized trial. Nutrition. 2011;27(4):440-444.
71.
HeylandDKCahillNEDhaliwalR. Enhanced protein-energy provision via the enteral route in critically ill patients: a single center feasibility trial of the PEP uP protocol. Crit Care. 2010;14(2):R78.
72.
Mowatt-LarssenCABrownROWojtysiakSLKudskKA. Comparison of tolerance and nutritional outcome between a peptide and a standard enteral formula in critically ill, hypoalbuminemic patients. JPEN J Parenter Enteral Nutr. 1992;16(1):20-24.
73.
HeimburgerDCGeelsWJThiesseKTBartolucciAA. Randomized trial of tolerance and efficacy of a small-peptide enteral feeding formula versus a whole-protein formula. Nutrition. 1995;11(4):360-364.
74.
Ali AbdelhamidYCousinsCESimJA. Effect of critical illness on triglyceride absorption. JPEN J Parenter Enteral Nutr. 2015;39(8):966-972.
75.
Strack van SchijndelRJWierdsmaNJvan HeijningenEMWeijsPJde GrootSDGirbesAR. Fecal energy losses in enterally fed intensive care patients: an explorative study using bomb calorimetry. Clin Nutr. 2006;25(5):758-764.
76.
QiuCChenCZhangW. A fat-modified enteral formula improves feeding tolerance in critically ill patients: a multicenter, single-blind, randomized controlled trial [published online September 8, 2015]. JPEN J Parenter Enteral Nutr.
77.
ChenYCChouSSLinLHWuLF. The effect of intermittent nasogastric feeding on preventing aspiration pneumonia in ventilated critically ill patients. J Nurs Res. 2006;14(3):167-180.
78.
CioconJOGalindo-CioconDJTiessenCGalindoD. Continuous compared with intermittent tube feeding in the elderly. JPEN J Parenter Enteral Nutr. 1992;16(6):525-528.
79.
Aguilera-MartinezRRamis-OrtegaECarratala-MunueraCFernandez-MedinaJMSaiz-VinuesaMDBarrado-NarvionMJ. Effectiveness of continuous enteral nutrition versus intermittent enteral nutrition in intensive care patients: a systematic review. JBI Database Syst Rev Implement Rep. 2014;12(1):281-317.
80.
MarikPE. Feeding critically ill patients the right ‘whey’: thinking outside of the box: a personal view. Ann Intensive Care. 2015;5(1):51.
81.
ChowdhuryAHMurrayKHoadCL. Effects of bolus and continuous nasogastric feeding on gastric emptying, small bowel water content, superior mesenteric artery blood flow, and plasma hormone concentrations in healthy adults: a randomized crossover study. Ann Surg. 2016;263(3):450-457.
82.
BoheJLowJFWolfeRRRennieMJ. Latency and duration of stimulation of human muscle protein synthesis during continuous infusion of amino acids. J Physiol. 2001;532(pt 2):575-579.
83.
WestDWBurdNACoffeyVG. Rapid aminoacidemia enhances myofibrillar protein synthesis and anabolic intramuscular signaling responses after resistance exercise. Am J Clin Nutr. 2011;94(3):795-803.
84.
HaranPHRivasDAFieldingRA. Role and potential mechanisms of anabolic resistance in sarcopenia. J Cachexia Sarcopenia Muscle. 2012;3(3):157-162.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
